ClinicalTrials.gg
CompletedNCT05702008Updated Jan 27, 2023

Social Media as an Information, Education and Communication Tool for Rabies Prevention: An Interventional Study

An interventional study of Rabies Information Education and Communication Material in Rabies, Health Education and Public Health, sponsored by Maulana Azad Medical College. Completed at 1 site in India. Per ClinicalTrials.gov, last updated 2023-01-27.

Sponsored by Maulana Azad Medical College · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Jul 2022, registered Jan 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Sex
All
01

Study summary

Background: Rabies is a fatal disease that can be avoided by treating animal bites promptly. Hence, post-exposure prophylaxis is critical. As a result, the National Rabies Control Program was approved under the 12th five-year plan in India. One of its strategies is to engage in Information, Education and Communication activities. Social media provides an opportunity for the quick and easy dissemination of research but is constrained by a lack of peer review and the risk of misinterpretation. The efficacy of a novel social media-based knowledge dissemination strategy for rabies prevention was tested in this study.

Methods: An experimental study design was followed, wherein 144 preclinical medical students of Maulana Azad Medical College, Delhi, India were included in each control and test group. The test group was administered the intervention, which exposed the participants to health education material via social media across a span of 30 days. Participants' knowledge, attitude and practices were observed before and after the study duration.

02

Conditions studied

  • Rabies
  • Health Education
  • Public Health
  • Preventive Health Services
03

In context

Rabies

114 studies on the registry are indexed under Rabies; 15 are open to participants now.

This study's enrollment of 300 is above the median of 201 across 104 interventional studies indexed under Rabies.

Browse Rabies studies →

Lead sponsor

Maulana Azad Medical College is the lead sponsor of 9 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult individuals who have a smartphone, internet access and are WhatsApp users
  • preclinical medical students, i.e., Bachelor of Medicine, Bachelor of Surgery (MBBS) 1st and 2nd professional year students

Exclusion criteria

Exclusion Criteria:

  • individuals who themselves have been a dog bite or rabies victim
  • individuals who have a dog bite or rabies victim in the household
  • individuals who developed the above criteria during the study duration were excluded from the data analysis
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
300 participants (actual)

Study arms

  • No intervention
    Control Group

    The participants in this study arm were administered no intervention.

  • Experimental
    Test Group

    The participants in this arm were administered the following intervention: The test group was administered the rabies IEC material available on the National Center for Disease Control (NCDC) website (https://ncdc.gov.in/index1.php?page=1\&ipp=All\&lang=1\&level=2\&sublinkid=502\&lid=428) in English and Hindi languages using a WhatsApp broadcast every 3 days for 30 days, in a cyclical manner. This material includes brochures, posters, short films, and informative documents designed to educate the general public about rabies prevention and post-exposure prophylaxis practices. Text messages, encouraging the participants to go through the material, were also a part of this intervention.

    Other: Rabies Information Education and Communication Material

Interventions

  • OtherRabies Information Education and Communication Material

    The test group was administered the rabies IEC material available on the National Center for Disease Control (NCDC) website (https://ncdc.gov.in/index1.php?page=1\&ipp=All\&lang=1\&level=2\&sublinkid=502\&lid=428) in English and Hindi languages using a WhatsApp broadcast every 3 days for 30 days, in a cyclical manner. This material includes brochures, posters, short films, and informative documents designed to educate the general public about rabies prevention and post-exposure prophylaxis practices. Text messages, encouraging the participants to go through the material, were also a part of this intervention.

06

What researchers measure

Primary outcomes

  1. To measure the impact of a social media-based dissemination strategy on information dissemination and retention for rabies IEC material among preclinical medical students

    The responses obtained through a KAP questionnaire were entered into an MS Excel file and analyzed using SPSS version 24. The responses were scored +1 for the correct answer, -1 for the incorrect answer, and 0 for the "Don't know" answer. Aggregated scores were categorized using Bloom's cut-off points for each of the 3 sections (knowledge, attitude, and practices): "good", if the score was between 80 and 100%, "moderate" if the score was between 60 and 79%, and "poor" if the score was less than 60%. Means and percentages of responses were calculated for both test and control groups, before and after the intervention. The changes in responses for both groups were measured and compared.

    Time frame: 2 months

07

Study locations

1 site
  • Maulana Azad Medical College
    Delhi, 110002, India
08

References and documents

Publications

  • Breland JY, Quintiliani LM, Schneider KL, May CN, Pagoto S. Social Media as a Tool to Increase the Impact of Public Health Research. Am J Public Health. 2017 Dec;107(12):1890-1891. doi: 10.2105/AJPH.2017.304098. No abstract available. PubMed 29116846 ↗
  • Aichner T, Grunfelder M, Maurer O, Jegeni D. Twenty-Five Years of Social Media: A Review of Social Media Applications and Definitions from 1994 to 2019. Cyberpsychol Behav Soc Netw. 2021 Apr;24(4):215-222. doi: 10.1089/cyber.2020.0134. Epub 2020 Oct 13. PubMed 33847527 ↗
  • Cinelli M, Quattrociocchi W, Galeazzi A, Valensise CM, Brugnoli E, Schmidt AL, Zola P, Zollo F, Scala A. The COVID-19 social media infodemic. Sci Rep. 2020 Oct 6;10(1):16598. doi: 10.1038/s41598-020-73510-5. PubMed 33024152 ↗
  • Dijkstra S, Kok G, Ledford JG, Sandalova E, Stevelink R. Possibilities and Pitfalls of Social Media for Translational Medicine. Front Med (Lausanne). 2018 Dec 6;5:345. doi: 10.3389/fmed.2018.00345. eCollection 2018. PubMed 30574495 ↗
  • Gatewood J, Monks SL, Singletary CR, Vidrascu E, Moore JB. Social Media in Public Health: Strategies to Distill, Package, and Disseminate Public Health Research. J Public Health Manag Pract. 2020 Sep/Oct;26(5):489-492. doi: 10.1097/PHH.0000000000001096. PubMed 32732723 ↗
  • Greene JA, Choudhry NK, Kilabuk E, Shrank WH. Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook. J Gen Intern Med. 2011 Mar;26(3):287-92. doi: 10.1007/s11606-010-1526-3. Epub 2010 Oct 13. PubMed 20945113 ↗
  • Rajagopalan MS, Khanna VK, Leiter Y, Stott M, Showalter TN, Dicker AP, Lawrence YR. Patient-oriented cancer information on the internet: a comparison of wikipedia and a professionally maintained database. J Oncol Pract. 2011 Sep;7(5):319-23. doi: 10.1200/JOP.2010.000209. Epub 2011 Aug 4. PubMed 22211130 ↗
  • Eljiz K, Greenfield D, Hogden A, Taylor R, Siddiqui N, Agaliotis M, Milosavljevic M. Improving knowledge translation for increased engagement and impact in healthcare. BMJ Open Qual. 2020 Sep;9(3):e000983. doi: 10.1136/bmjoq-2020-000983. PubMed 32943430 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2022 to primary completion in Aug 2022, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 18, 2023
First posted
Jan 27, 2023
StartActual
Jul 1, 2022
Primary completionActual
Aug 1, 2022
CompletionActual
Sep 1, 2022
Last update
Jan 27, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05702008
Lead sponsor
Maulana Azad Medical College
Responsible party
Jay Verma (Principal Investigator, Maulana Azad Medical College) — Principal investigator
First posted
Jan 27, 2023
Start date
Jul 1, 2022
Primary completion
Aug 1, 2022
Completion
Sep 1, 2022
Last update
Jan 27, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion